TickerFacts.

Immuneering Corp (IMRX): Revenue

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Revenue is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$0
Year ended 2023-12-31
$2.31M2020-12-31: $2.31M2021-12-31: $2.08M2022-12-31: $317.0K2023-12-31: $0$0
2020-12-31 Revenue (USD) 2023-12-31
Period endedRevenueChange YoYSource filing
2023-12-31$0-100.0%2024-03-01, From 2023-01-01
2022-12-31$317.0K-84.8%2024-03-01, From 2022-01-01
2021-12-31$2.08M-10.0%2023-03-06, From 2021-01-01
2020-12-31$2.31Mn/a2022-03-10, From 2020-01-01